NCT04873076

Brief Summary

In this randomized controlled trial, amount of sedation exposure and patient satisfaction is evaluated in patients undergoing catheter ablation for rhythm disorders via an audiovisual distraction. Patients are randomized into intervention group (adiovisual distraction) or controll (no intervention).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2019

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 25, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2020

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2020

Completed
1.1 years until next milestone

First Posted

Study publicly available on registry

May 5, 2021

Completed
Last Updated

May 5, 2021

Status Verified

April 1, 2021

Enrollment Period

4 months

First QC Date

January 25, 2020

Last Update Submit

April 29, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change of analgosedation dosage

    The change of analgosedation dose is measured by comparing the amount of sedation necessary for the procedure in experimental and controll arm. Remifentanyl (Ultiva) is measured in µg/kg/hour Midazolam (Dormicum) is measured in mg/kg/hour

    during the procedure (electrophysiological examination on the heart)

  • Change of stress and anxiety level

    The vital parameter blood pressure (in mmHg) serve as surrogate parameter for anxiety and stress.

    during the procedure (electrophysiological examination on the heart)

Secondary Outcomes (1)

  • Patient satisfaction

    evaluation before, immediately after and one day after the procedure

Study Arms (2)

Audiovisual distraction using 2d video glasses from HappyMed GmbH

EXPERIMENTAL

During the catheter ablation, the patients in the intervention group receive 2D video glasses with headphones. Immediately before and after the procedure they receive a questionnaire. During the procedure vital parameters of all patients regardless of the studygroup are monitored using "Zoll X-Series Monitor Defibrillator. The study includes blood pressure (in mmHg), heart rate (in beats per minute) and patient's level of alertness, which is assessed using the Richmond Agitation-Sedation Scale(RAAS). During the procedure the patients in the intervention group receive the glasses and remote control. All patients receive their individual dosage to ensure painless ablation. The drugs used are limited to the opioids remifentanil and benzodiazepine midazolam.

Device: Audiovisual distraction using 2d video glasses from HappyMed GmbH

Controll arm

NO INTERVENTION

In patients in the control group, catheter ablation is performed as usual without the use of video glasses. They receive immediately before and after the ablation the same questionnaire as the patients in experimental arm. (Omitting the question about the videoglasses). While the procedure is performed, the analgosediation is as well in the controll arm as in the experimental arm titrated until the patient is treated, sedated and painless.

Interventions

Patients receive optical and acustical relaxing material during the procedure by using 2d video glasses from HappyMed GmbH

Audiovisual distraction using 2d video glasses from HappyMed GmbH

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient undergoing catheter ablation for rhythm disorders

You may not qualify if:

  • epilepsy
  • age \<18 years
  • visus \<-5 dpt or \>+2 dpt

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Essen

Essen, North Rhine-Westphalia, 45147, Germany

Location

MeSH Terms

Conditions

Arrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2020

First Posted

May 5, 2021

Study Start

November 20, 2019

Primary Completion

March 13, 2020

Study Completion

March 14, 2020

Last Updated

May 5, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations